(Q50459301)

English

Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.

scientific article published on 28 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

1 reference

based on heuristic

inferred from title

author name string

Zhiguo Zhang

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Shudong Wang

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Shanshan Zhou

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Xiaoqing Yan

4

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Yonggang Wang

5

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Jing Chen

6

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Nicholas Mellen

7

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Maiying Kong

8

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Junlian Gu

9

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Yi Tan

10

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Yang Zheng

11

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Lu Cai

12

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

publication date

28 September 2014

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

77

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

42-52

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Diabetes mellitus and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

New type of cardiomyopathy associated with diabetic glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Management of cellular energy by the AMP-activated protein kinase system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

LKB1 is the upstream kinase in the AMP-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Autophagy regulates lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Regulation of myocardial triacylglycerol synthesis and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

New insights into insulin resistance in the diabetic heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

The role of AMP-activated protein kinase in mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of Nrf2 expression and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Deconstructing type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

A novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Kidney involvement in a nongenetic rat model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Validation of volume-pressure recording tail-cuff blood pressure measurements

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Magnolia extract (BL153) protection of heart from lipid accumulation caused cardiac oxidative damage, inflammation, and cell death in high-fat diet fed mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Impact of diabetes mellitus on myocardial lipid deposition: an autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Metformin use and mortality in ambulatory patients with diabetes and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

AMPK signalling and the control of substrate use in the heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

The MAP1-LC3 conjugation system is involved in lipid droplet formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

ULK1 plays a critical role in AMPK-mediated myocardial autophagy and contractile dysfunction following acute alcohol challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Malonyl CoA control of fatty acid oxidation in the diabetic rat heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Role of malonyl-CoA in heart disease and the hypothalamic control of obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

The PPARalpha-PGC-1alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Nitric oxide and mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein tra

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.09.022

7 January 2021

Identifiers

10.1016/J.YJMCC.2014.09.022

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/25268649

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50459301&oldid=1532804986"